Peter Bou Dib: Understanding von Willebrand Factor in Bleeding and Thrombotic Disorders
Peter Bou Dib, Key Account Manager at Sino Biological Europe, shared a post on LinkedIn about a recent article by François Depasse et al, published in Expert Review of Hematology:
”Understanding Von Willebrand Factor (VWF): Key to Diagnosing Bleeding and Thrombotic Disorders
Von Willebrand factor is essential for blood clotting and vascular integrity.
Defects in VWF cause the most common inherited bleeding disorder—von Willebrand disease (VWD)—and also play a role in acquired bleeding syndromes and thrombotic conditions.
Key Insights:
- VWD diagnosis relies on a panel of specialized lab tests measuring VWF antigen and activity, factor VIII, and multimer analysis.
- VWF levels vary with age, pregnancy, blood group, inflammation, and other clinical factors.
- Acquired von Willebrand syndrome occurs in settings like cardiovascular disease, hematological malignancies, and autoimmune disorders.
- VWF is involved in thrombotic microangiopathies linked to ADAMTS13 dysfunction.
- Genetic testing complements phenotypic assays, especially for complex cases.”
Title: Von Willebrand factor is a multifaceted player in hemostasis requiring a diverse array of analytical and diagnostic approaches
Authors: François Depasse, Nikolaus B. Binder, Mariona Bono, Matthias Germer, Michael Heins, Martina Leplatoni, Jürgen Patzke, Stephan Schwers, Michael Spannagl, Peter L. Turecek
Read the Full Article on Expert Review of Hematology
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia
-
Oct 10, 2026, 17:53Assessing Frailty in Adults With Hemophilia – JTH
-
Oct 10, 2026, 17:52Fatma Sadeghi: Reducing Maternal Health Inequalities Through Nursing Advocacy
-
Oct 10, 2026, 17:50Grzegorz Hensler: How Apheresis Transformed Blood Cell Separation and Collection
-
Oct 10, 2026, 17:47Hemant K Sharma: Japan’s Universal Artificial Blood Research – A Potential Breakthrough in Transfusion Medicine
-
Oct 10, 2026, 17:40John Strouse: Learning About Bleeding Disorders and Sickle Cell Disease at FWGBD
-
Oct 10, 2026, 17:34Mae Caime: Speaking at the Annual Women’s Retreat for the Hemophilia Community in Florida
-
Oct 10, 2026, 17:30Chokri Ben Lamine: PNH beyond the Textbook Triad
-
Oct 10, 2026, 17:29Ruah Alyamany: Thrombosis and Anticoagulation in Hematological Malignancies at SOHO KSA 2026